Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Technosphere Insulin Inhalation Powder for Postprandial Glucose in Diabetes
NCT00747006Phase 2Terminated
- Sponsor
- MannKind
- Start
- Sep 2008
- Primary completion
- Feb 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of TI-Inhalation Powder B in type 1 diabetes mellitus (T1D), type 2 diabetes mellitus (T2DM), sponsored by MannKind. Started Sep 2008; status: terminated.
02
Drugs
TI-Inhalation Powder B
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00747006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00747006.